FDA Approves Anthrax Drug For Storage In National Stockpile

FDA approved Anthrasil, Anthrax Immune Globulin Intravenous, to treat patients with inhalational anthrax, the disease developed when a person is exposed to toxic levels of anthrax. The drug is supposed to be used in combination with other antibacterial drugs, the agency said. “Today’s approval provides an important additional treatment to other FDA-approved therapies for inhalational anthrax, a life-threatening disease,” said Karen Midthun, director of FDA’s Center for Biologics Evaluation and Research, in a statement Wednesday (March 25). “This product will...